» Articles » PMID: 25605764

Combinational Deletion of Three Membrane Protein-encoding Genes Highly Attenuates Yersinia Pestis While Retaining Immunogenicity in a Mouse Model of Pneumonic Plague

Abstract

Previously, we showed that deletion of genes encoding Braun lipoprotein (Lpp) and MsbB attenuated Yersinia pestis CO92 in mouse and rat models of bubonic and pneumonic plague. While Lpp activates Toll-like receptor 2, the MsbB acyltransferase modifies lipopolysaccharide. Here, we deleted the ail gene (encoding the attachment-invasion locus) from wild-type (WT) strain CO92 or its lpp single and Δlpp ΔmsbB double mutants. While the Δail single mutant was minimally attenuated compared to the WT bacterium in a mouse model of pneumonic plague, the Δlpp Δail double mutant and the Δlpp ΔmsbB Δail triple mutant were increasingly attenuated, with the latter being unable to kill mice at a 50% lethal dose (LD50) equivalent to 6,800 LD50s of WT CO92. The mutant-infected animals developed balanced TH1- and TH2-based immune responses based on antibody isotyping. The triple mutant was cleared from mouse organs rapidly, with concurrent decreases in the production of various cytokines and histopathological lesions. When surviving animals infected with increasing doses of the triple mutant were subsequently challenged on day 24 with the bioluminescent WT CO92 strain (20 to 28 LD50s), 40 to 70% of the mice survived, with efficient clearing of the invading pathogen, as visualized in real time by in vivo imaging. The rapid clearance of the triple mutant, compared to that of WT CO92, from animals was related to the decreased adherence and invasion of human-derived HeLa and A549 alveolar epithelial cells and to its inability to survive intracellularly in these cells as well as in MH-S murine alveolar and primary human macrophages. An early burst of cytokine production in macrophages elicited by the triple mutant compared to WT CO92 and the mutant's sensitivity to the bactericidal effect of human serum would further augment bacterial clearance. Together, deletion of the ail gene from the Δlpp ΔmsbB double mutant severely attenuated Y. pestis CO92 to evoke pneumonic plague in a mouse model while retaining the required immunogenicity needed for subsequent protection against infection.

Citing Articles

Live Plague Vaccine Development: Past, Present, and Future.

Anisimov A, Vagaiskaya A, Trunyakova A, Dentovskaya S Vaccines (Basel). 2025; 13(1).

PMID: 39852845 PMC: 11768842. DOI: 10.3390/vaccines13010066.


The Protective Effect of IL-17A in Pneumonic Plague Can Be Compensated by Effective Vaccines and Immunization Strategies in Mice.

Hendrix E, Sha J, Kilgore P, Neil B, Verma A, Chopra A Vaccines (Basel). 2025; 12(12.

PMID: 39772023 PMC: 11680114. DOI: 10.3390/vaccines12121361.


Progress on the research and development of plague vaccines with a call to action.

Williamson E, Kilgore P, Hendrix E, Neil B, Sha J, Chopra A NPJ Vaccines. 2024; 9(1):162.

PMID: 39242587 PMC: 11379892. DOI: 10.1038/s41541-024-00958-1.


and Plague: some knowns and unknowns.

Yang R, Atkinson S, Chen Z, Cui Y, Du Z, Han Y Zoonoses (Burlingt). 2023; 3(1).

PMID: 37602146 PMC: 10438918. DOI: 10.15212/zoonoses-2022-0040.


Contributions of Yersinia pestis outer membrane protein Ail to plague pathogenesis.

Kolodziejek A, Hovde C, Minnich S Curr Opin Infect Dis. 2022; 35(3):188-195.

PMID: 35665712 PMC: 9186061. DOI: 10.1097/QCO.0000000000000830.


References
1.
Anisimov A, Shaikhutdinova R, Pankina L, Feodorova V, Savostina E, Bystrova O . Effect of deletion of the lpxM gene on virulence and vaccine potential of Yersinia pestis in mice. J Med Microbiol. 2007; 56(Pt 4):443-453. DOI: 10.1099/jmm.0.46880-0. View

2.
Glauser M, Zanetti G, Baumgartner J, Cohen J . Septic shock: pathogenesis. Lancet. 1991; 338(8769):732-6. DOI: 10.1016/0140-6736(91)91452-z. View

3.
Edwards R, Keller L, Schifferli D . Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene. 1998; 207(2):149-57. DOI: 10.1016/s0378-1119(97)00619-7. View

4.
Oyston P, Prior J, Kiljunen S, Skurnik M, Hill J, Titball R . Expression of heterologous O-antigen in Yersinia pestis KIM does not affect virulence by the intravenous route. J Med Microbiol. 2003; 52(Pt 4):289-294. DOI: 10.1099/jmm.0.05044-0. View

5.
Erova T, Rosenzweig J, Sha J, Suarez G, Sierra J, Kirtley M . Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine. Clin Vaccine Immunol. 2012; 20(2):227-38. PMC: 3571283. DOI: 10.1128/CVI.00597-12. View